EUVIMEDEUVIMED entdecken
Leserbrief

TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival

Noah S Meimoun iD, Alexander D Sherry iD, Ethan B Ludmir iD, Timothy A Lin iD

Journal of Clinical Oncology · 10.08.2026 · 44 (23) · 2254-2255

DOI: 10.1200/jco-26-00267 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.08.2026. Verfasst von Noah S Meimoun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Noah S. Meimoun, BA, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Noah S. Meimoun, BA, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Alexander D. Sherry, MD, Department of Radiation Oncology, The Mayo…

ORCID-Profile: Noah S Meimoun, Alexander D Sherry, Ethan B Ludmir, Timothy A Lin

Zitieren

APA

Meimoun, N. S., Sherry, A. D., Ludmir, E. B., & Lin, T. A. (2026). TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival. Journal of Clinical Oncology, 44(23), 2254-2255. https://doi.org/10.1200/jco-26-00267

Vancouver

Meimoun NS, Sherry AD, Ludmir EB, Lin TA. TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival. Journal of Clinical Oncology. 2026;44(23):2254-2255. doi:10.1200/jco-26-00267

BibTeX
@article{Meimoun2026,
  author = {Meimoun, Noah S and Sherry, Alexander D and Ludmir, Ethan B and Lin, Timothy A},
  title = {TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {23},
  pages = {2254--2255},
  doi = {10.1200/jco-26-00267}
}
Kostenlos starten →